Member Info for JRDC

Superb news, interested to see who this partner is and what tech they're using. None of the aptamer LFT are any good so doubt we're licensing that.

Bluelight- it's investing, the more a company promotes what they might achieve in 2, 5 10 years even they'll bring in investment, and can justify huge p/e ratio. Jam is why people invest. If they released a load of products to little fanfare, gave no indication of how well they're selling and to whom other than minimal legal requirements and a vague 50/50, also say they can't/won't predict future revenues, btw we're taking our biggest customer to court and may impact what has already been reported, the SP will die.

Looks like no news then between now and June. DHSC which is half our revenue is worth £4. So if everything resolved (but obv no new govt contracts), that puts nova back to £8 at best. At least GM had the courtesy to let holders gain opportunity value elsewhere for a month or so. Porky - it's not too late to move to Avacta for a month to make some of your losses back, maybe you'll see what all the fuss is about.

I missed the word saliva before when skim reading.

So the govt test will be AN and our own is a spit one? Does that mean the recent validation was done on saliva too then instead of nostril? Let's hope that's cleared up, if it's saliva with a 98% accuracy, that's astounding imo.

Not quite apples, as these are NP, CT <30

https://www.sciencedirect.com/science/article/pii/S0163445321001912

Shows how damn good our test is though. Surescreen is only 70% sensitivity, would probably be far lower if it just tickled the nostrils. I don't think the market has realised how bad the other leading tests are, and why ours is the only one in the world that is accurate, cost effective, scalable, suitable for general public to do (read: idiot proof), fine for parents to use on young children and can be easily adapted for future strains.

You can be sure this news would have landed on the desk of every LFT producing pharma's CEO by the morning, and they'll be googling avacta if they haven't already. Als inbox could be quite full by 8.00am tomorrow.

Agree the only way to mass test is with LFT and avacta will be huge in comparison to Nova one day, but there is still a market for PCR, especially one that seemingly picks up every major variant. I'm down 15% on nova from once being 100% up, but I've yet to find anyone who thinks a company with over £100m cash in the bank and earning £35m a quarter with up to 80% profit margin excluding DHSC orders are worth way under £300m. I'm sure the dispute will be resolved over the coming months. GM is even more vague than AS.

At £3 thats pretty much the market saying £0 revenue for 2022 onwards. GM can't / won't confirm otherwise, hence this is where we're at. And yes, its ridiculous the thought of no revenue a year from now.

Why not take company private at a 50% premium to current prices, and then refloat next year at £15.

We could hit £200m mcap by end of May.

that I might breach my lifetime allowance a year from now.

Shame there's now feck all chance of a govt order thanks to a daft decision to sue your best customer rather than fight for a new tender. If the RNS had simply said govt had decided not to continue with contract, whilst disappointing, we remain on good terms, btw we made just as much from private sales, I doubt the SP would be below £5 right now.

It's making us look worse than M&S and cakegate.

What was the answer to the question, Shoc? Don't tell me you've had to sign an NDA as well...

Keep us updated Shoc please, I would listen but I would end up randomly typing BAMS in my sql code

Knowing my luck, Avacta will release the test, announce a £1bn order, and then Russia will invade ukraine sending the SP crashing. Only half joking there, I intend on cashing in a good chunk of my ISA soon on next decent breakout

GM is more likely to say 'The optimistic ODDO note does not reflect future trading estimates'. I'd prefer he keep to just releasing sales figures and keep opinion to himself

Agree cat. I think GM sees shareholders as a nuisance at best, or viewed with contempt at worst. It's like they're a 90's company with little grasp of social media and how events unfold when information spreads quickly.

The mcap is low, even before it went t!ts, because the market doesn't believe current management are capable. Amateurish RNSs, little to no sales information (they couldn't even be ars3d with a trading update other quarter) and months of radio silence haven't helped, especially as we now know NDAs weren't the reason. Board have taken us as far as they can imo, unless they give us good reason to keep faith. But if they want to be seen as a billion pound company, they very quickly need to start acting like one. Stick this month's earnings in to PR, get on national TV, radio,setup free testing stations in France, Germany, invite politicians on as advisory role, donate funds to MPs who constituents hit badly by covid, buy a senator a yacht etc.

Can we as shareholders ask if nova are under a TO offer? The answer will either be 'no', or 'we can't disclose that information'.

I thought the UK govt had blocked all take overs from key UK industries, so I think the answer is no and it's just the MMs grabbing what they can(and me, these are bargain prices, tempted to sell some avacta even)

We need GM to provide details of the dispute, and what the worst possible financial case will be for us - i hope at worst our liability is limited to the value of the contract (£150m?), otherwise whoever signed it needs firing.

If this drops below £4 I'll probably add my holding, if amigo can come back from the abyss so can nova

Wasn't that bad? My 6 year old would struggle to write a worse one. No phase 2, phase 1 in dispute, 2020 revenues having to be reworked, zero chance of future contracts with UK govt, reputation possibly tarnished for RoW govt orders, naive management so now we have a recruitment drive in place to try and rescue current contract, GM unable to forecast future revenues - currently £12 a month private but I'm guessing that is due to dry up, no other RNS worth contracts, no good news to combat the imminent move towards LFT and to top it off no chance of takeover due to UK Govt rules to put us out our misery. Even porky will struggle to ramp this back to £12. I topped up at £4.40 to average down on hope it might hit £5 level over next fortnight, but if sub £7 was hit when the market was blissfully unaware of the impending doom I think £6 is a tad optimistic.

Sales outside of govt contract (£36m or so) is better than I thought, if there is any silver lining. I think £5-£6 a fairer value. £10+ will probably never be seen again unless we get an unlikely large US order. If the contracts are worded as well as our RNSs are then I doubt we'll be successful in court.

Been a fun ride chaps, first share to see me 50% down, 100% up and then 15% down at £4.30ish in a year.

Good luck those intending to stay in over next few years

Ah well, can't win them all. Will see how the dust settles over next week or so and see if it gets back to over £5 and call it a day. Glad I was a bit cautious and not succumbing to greed.

Not expecting another trading update until June/July, so probably safe to w/d soon and try my chances elsewhere for now.